Folke Morén

2.3k total citations
29 papers, 1.9k citations indexed

About

Folke Morén is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Folke Morén has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Folke Morén's work include Inhalation and Respiratory Drug Delivery (27 papers), Asthma and respiratory diseases (11 papers) and Pharmaceutical studies and practices (6 papers). Folke Morén is often cited by papers focused on Inhalation and Respiratory Drug Delivery (27 papers), Asthma and respiratory diseases (11 papers) and Pharmaceutical studies and practices (6 papers). Folke Morén collaborates with scholars based in United Kingdom, Sweden and Kuwait. Folke Morén's co-authors include S W Clarke, Stanton Newman, Stephen P. Newman, D Pavia, Lars Borgström, N F Sheahan, Eva Bondesson, N Talaee, Ann Millar and Myrna Dolovich and has published in prestigious journals such as European Respiratory Journal, International Journal of Pharmaceutics and Thorax.

In The Last Decade

Folke Morén

29 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Folke Morén United Kingdom 20 1.6k 922 149 147 136 29 1.9k
D Pavia United Kingdom 31 3.0k 1.9× 1.3k 1.4× 94 0.6× 141 1.0× 115 0.8× 118 3.5k
Evangelia Daviskas Australia 31 2.6k 1.6× 1.3k 1.4× 110 0.7× 39 0.3× 56 0.4× 52 3.0k
Kurt Nikander Finland 26 2.4k 1.5× 2.0k 2.1× 47 0.3× 204 1.4× 58 0.4× 55 2.7k
Richard C. Ahrens United States 25 2.4k 1.5× 1.1k 1.2× 34 0.2× 157 1.1× 93 0.7× 60 2.8k
Sunalene G. Devadason Australia 24 1.8k 1.1× 1.2k 1.3× 45 0.3× 251 1.7× 24 0.2× 52 2.2k
Gary R. Pitcairn United Kingdom 20 999 0.6× 474 0.5× 174 1.2× 40 0.3× 27 0.2× 32 1.1k
Martyn F. Biddiscombe United Kingdom 16 1.2k 0.8× 686 0.7× 92 0.6× 50 0.3× 75 0.6× 30 1.3k
Graham K. Crompton United Kingdom 15 1.1k 0.7× 917 1.0× 36 0.2× 97 0.7× 26 0.2× 25 1.3k
M. L. Thomson United Kingdom 25 991 0.6× 455 0.5× 37 0.2× 60 0.4× 25 0.2× 56 1.6k
N. R. Labiris Canada 13 1.3k 0.8× 354 0.4× 360 2.4× 51 0.3× 17 0.1× 18 1.6k

Countries citing papers authored by Folke Morén

Since Specialization
Citations

This map shows the geographic impact of Folke Morén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Folke Morén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Folke Morén more than expected).

Fields of papers citing papers by Folke Morén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Folke Morén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Folke Morén. The network helps show where Folke Morén may publish in the future.

Co-authorship network of co-authors of Folke Morén

This figure shows the co-authorship network connecting the top 25 collaborators of Folke Morén. A scholar is included among the top collaborators of Folke Morén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Folke Morén. Folke Morén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borgström, Lars, et al.. (1994). Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. European Respiratory Journal. 7(1). 69–73. 236 indexed citations
2.
Thorsson, Lars, et al.. (1993). Nasal distribution of budesonide inhaled via a powder inhaler.. PubMed. 31(1). 7–10. 43 indexed citations
3.
Morén, Folke, Myrna Dolovich, & Michael T. Newhouse. (1993). Aerosols in Medicine : Principles, Diagnosis and Therapy. Medical Entomology and Zoology. 104 indexed citations
4.
Borgström, Lars, et al.. (1992). Pulmonary Deposition of Inhaled Terbutaline: Comparison of Scanning Gamma Camera and Urinary Excretion Methods. Journal of Pharmaceutical Sciences. 81(8). 753–755. 76 indexed citations
5.
Newman, Stephen P., et al.. (1991). Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy. International Journal of Pharmaceutics. 74(2-3). 209–213. 116 indexed citations
6.
Newman, Stanton, et al.. (1989). Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. European Respiratory Journal. 2(3). 247–252. 101 indexed citations
7.
Morén, Folke, et al.. (1988). A comparative distribution study of two procedures for administration of nose drops. Acta Oto-Laryngologica. 106(3-4). 286–290. 23 indexed citations
8.
Newman, Stephen P., George Woodman, Folke Morén, & S W Clarke. (1988). Bronchodilator therapy with nebuhaler: how important is the delay between firing the dose and inhaling?. British Journal of Diseases of the Chest. 82(3). 262–267. 5 indexed citations
9.
Morén, Folke. (1987). Dosage Forms and Formulations for Drug Administration to the Respiratory Tract. Drug Development and Industrial Pharmacy. 13(4-5). 695–728. 16 indexed citations
10.
Newman, Stanton, Folke Morén, & S W Clarke. (1987). The nasal distribution of metered does inhalers. The Journal of Laryngology & Otology. 101(2). 127–132. 60 indexed citations
11.
Sp, Newman, Folke Morén, & Clarke Sw. (1987). Deposition pattern from a nasal pump spray.. PubMed. 25(2). 77–82. 51 indexed citations
12.
Morén, Folke, et al.. (1984). Mode of Inhalation for Trained and Untrained Asthmatics Using a Pressurized Aerosol. Respiration. 45(1). 56–60. 8 indexed citations
13.
Newman, Stanton, et al.. (1984). Improvement of pressurised aerosol deposition with Nebuhaler spacer device.. Thorax. 39(12). 935–941. 204 indexed citations
14.
Newman, Stephen P., et al.. (1984). The effect of changes in particle size on the deposition of pressurized inhalation aerosols. International Journal of Pharmaceutics. 19(3). 333–337. 11 indexed citations
15.
Rees, P. J., T.J.H. Clark, & Folke Morén. (1982). The importance of particle size in response to inhaled bronchodilators.. PubMed. 119. 73–8. 54 indexed citations
16.
Morén, Folke. (1981). Pressurized aerosols for oral inhalation. International Journal of Pharmaceutics. 8(1). 1–10. 23 indexed citations
17.
Morén, Folke & Jan Andersson. (1980). Fraction of dose exhaled after administration of pressurized inhalation aerosols. International Journal of Pharmaceutics. 6(3-4). 295–300. 37 indexed citations
18.
Morén, Folke, et al.. (1980). Investigation of assay procedures for pressurized inhalation aerosols. International Journal of Pharmaceutics. 5(4). 287–290. 2 indexed citations
19.
Morén, Folke, et al.. (1979). In vitro dose sampling from pressurized inhalation aerosols investigaton of procedures in BPC and NF. International Journal of Pharmaceutics. 3(6). 335–340. 3 indexed citations
20.
Morén, Folke. (1978). Drug deposition of pressurized inhalation aerosols I. Influence of actuator tube design. International Journal of Pharmaceutics. 1(4). 205–212. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026